Organon and Samsung Bioepsis were first to launch biosimilar Hadlima (adalimumab-bwwd ... aiming to cut injection volume by half and result in fewer injections in particular patients.

In 2018, after the FDA approval of additional indications, AbbVie released a citrate-free high-concentration (100mg/ml) formulation of the drug, designed to decrease injection volume for higher ...

Free trial. The Fortra FileCatalyst Workflow is vulnerable to an SQL injection vulnerability that could allow remote unauthenticated attackers to create rogue admin users and manipulate data on ...

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

In its place, the PBM included the Humira-referenced biosimilars Hyrimoz, Hadlima and adalimumab-fkjp (an unbranded product). Hyrimoz appears to be the most favored biosimilar. While removal of ...